Namenda (memantine)
... Namenda is generally well tolerated. The most frequent side effects reported with Namenda include dizziness, headache, confusion, constipation, sleepiness, fatigue, and general body ache and pain. These adverse effects were more frequent at the 20-mg/day dosage, but in most cases side effects are us ...
... Namenda is generally well tolerated. The most frequent side effects reported with Namenda include dizziness, headache, confusion, constipation, sleepiness, fatigue, and general body ache and pain. These adverse effects were more frequent at the 20-mg/day dosage, but in most cases side effects are us ...
Drug Name Valproate, Sodium Valproate
... Anticonvulsant, Neuropathic pain, bipolar disorder, migraine Adult doses Epilepsy: initially 15mg/kg in divided doses increasing at twice weekly intervals by 200mg according to response. Maintenance dose rarely > 40mg/kg Bipolar Disorder: 500-2000mg daily Migraine Prophylaxis: 200-400mg bd Neuropath ...
... Anticonvulsant, Neuropathic pain, bipolar disorder, migraine Adult doses Epilepsy: initially 15mg/kg in divided doses increasing at twice weekly intervals by 200mg according to response. Maintenance dose rarely > 40mg/kg Bipolar Disorder: 500-2000mg daily Migraine Prophylaxis: 200-400mg bd Neuropath ...
File
... o Praziquantel should be taken with food and not chewed due to a bitter taste. o It is rapidly absorbed after oral administration and distributes into the cerebrospinal fluid (CSF). o The drug is extensively metabolized, and the inactive metabolites are excreted primarily in the urine. o Common adve ...
... o Praziquantel should be taken with food and not chewed due to a bitter taste. o It is rapidly absorbed after oral administration and distributes into the cerebrospinal fluid (CSF). o The drug is extensively metabolized, and the inactive metabolites are excreted primarily in the urine. o Common adve ...
NEWS YOU CAN USE 2015 06 UPD
... (memantine/donepezil) and 28/10 mg strengths • Capsules can be opened and sprinkled onto food for patients that have difficulty swallowing 05/20/2015 Pharmacy Times ...
... (memantine/donepezil) and 28/10 mg strengths • Capsules can be opened and sprinkled onto food for patients that have difficulty swallowing 05/20/2015 Pharmacy Times ...
VIOXX (ROFECOXIB)
... ROFETAB is contraindicated in patients with known hypersensitivity to rofecoxib or any other component of the formulation. ROFETAB should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. ...
... ROFETAB is contraindicated in patients with known hypersensitivity to rofecoxib or any other component of the formulation. ROFETAB should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. ...
ORIGINAL AND GENERIC AEDs IN THE TREATMENT OF EPILEPSY
... Objective. This article presents the state-of-the-art concerning the possible consequences of substitution of original drugs with generic drugs (and vice versa) and substitution of one generic drug with another generic drug in the treatment of epilepsy (exchange of pharmaceutical preparations). Revi ...
... Objective. This article presents the state-of-the-art concerning the possible consequences of substitution of original drugs with generic drugs (and vice versa) and substitution of one generic drug with another generic drug in the treatment of epilepsy (exchange of pharmaceutical preparations). Revi ...
Midodrine Information Leaflet
... The usual starting dose is 2.5mg 2 – 3 times daily The dose should be increased at intervals of 3 – 5 days until the optimal response is obtained. Most patients are controlled on doses at or below 30mg daily in divided doses Doses should be taken in the morning, at noon and evening. The la ...
... The usual starting dose is 2.5mg 2 – 3 times daily The dose should be increased at intervals of 3 – 5 days until the optimal response is obtained. Most patients are controlled on doses at or below 30mg daily in divided doses Doses should be taken in the morning, at noon and evening. The la ...
Savaysa
... stroke. While warfarin is highly effective in reducing the risk of stroke in patients with atrial fibrillation, it increases the risk of bleeding. Savaysa demonstrated significantly less major bleeding compared to warfarin. As with other FDA-approved anti-clotting drugs, bleeding, including life-thr ...
... stroke. While warfarin is highly effective in reducing the risk of stroke in patients with atrial fibrillation, it increases the risk of bleeding. Savaysa demonstrated significantly less major bleeding compared to warfarin. As with other FDA-approved anti-clotting drugs, bleeding, including life-thr ...
ETOGESIC SR
... avoided by patients with peptic ulcer disease or poor kidney function. Use in Pregnancy & Lactation Pregnancy : There are no adequate and well controlled studies in pregnant women. It should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Lactation : It ...
... avoided by patients with peptic ulcer disease or poor kidney function. Use in Pregnancy & Lactation Pregnancy : There are no adequate and well controlled studies in pregnant women. It should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Lactation : It ...
Metrifonate
... biotransformation of mertifonate occurs independently of the hepatic cytochrome P450 It is slowly and non-enzymatically transformed to DDVP which is PH dependent Serum t½ is 2 hours ...
... biotransformation of mertifonate occurs independently of the hepatic cytochrome P450 It is slowly and non-enzymatically transformed to DDVP which is PH dependent Serum t½ is 2 hours ...
Glicron CR Capsule
... Pregnancy: Gliclazide should not be used in pregnancy. Nursing mothers: It has not been established whether gliclazide is secreted in human milk. However, other sulfonylureas have been found in breast milk and there is evidence to suggest that gliclazide differs from the group in this respect. ADVER ...
... Pregnancy: Gliclazide should not be used in pregnancy. Nursing mothers: It has not been established whether gliclazide is secreted in human milk. However, other sulfonylureas have been found in breast milk and there is evidence to suggest that gliclazide differs from the group in this respect. ADVER ...
Text for Commercial Carton of Omastin Duo (1 Fluconazole 150 mg
... Dosage and administration: Adults and children > 12 years of age: 400 mg 1 Tablet twice daily. The dosage may be increased to t.i.d. according to the prescribing physician. The dosage (800 mg/ day) may be decreased according to medical prescription in the Very elderly patients with concomitant cardi ...
... Dosage and administration: Adults and children > 12 years of age: 400 mg 1 Tablet twice daily. The dosage may be increased to t.i.d. according to the prescribing physician. The dosage (800 mg/ day) may be decreased according to medical prescription in the Very elderly patients with concomitant cardi ...
SECZYL TABLET
... Has a longer terminal elimination half-life (approximately 17 to 29 hours) than commonly used drugs in this class. Secnidazole have a much longer half-life than Metronidazole, allowing single-dose or once daily administration. DOSAGE One day treatment: Secnidazole is given 2 gm as a single dose af ...
... Has a longer terminal elimination half-life (approximately 17 to 29 hours) than commonly used drugs in this class. Secnidazole have a much longer half-life than Metronidazole, allowing single-dose or once daily administration. DOSAGE One day treatment: Secnidazole is given 2 gm as a single dose af ...
1301 Pharmacology Drug List
... pregnant women, especially first trimester; and in infants younger than age 6 months (oral form). Major Adverse Effects 1. CNS: drowsiness, dysarthria, slurred speech, tremor, transient amnesia, fatigue, ataxia, headache, insomnia, paradoxical anxiety, hallucinations, minor changes in EEG patters, p ...
... pregnant women, especially first trimester; and in infants younger than age 6 months (oral form). Major Adverse Effects 1. CNS: drowsiness, dysarthria, slurred speech, tremor, transient amnesia, fatigue, ataxia, headache, insomnia, paradoxical anxiety, hallucinations, minor changes in EEG patters, p ...
for immediate release by the drug control authority ministry
... The Drug Control Authority (DCA) is issuing this public statement to inform patients and health care professionals about new safety concerns relating to Zelmac (tegaserod maleate). A new safety analysis conducted by the United States Food and Drug Administration (US FDA) on Zelnorm (the brand name u ...
... The Drug Control Authority (DCA) is issuing this public statement to inform patients and health care professionals about new safety concerns relating to Zelmac (tegaserod maleate). A new safety analysis conducted by the United States Food and Drug Administration (US FDA) on Zelnorm (the brand name u ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.